Skip to content

Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01119729
Enrollment
803
Registered
2010-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2010-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection., Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,, HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication

Keywords

Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy

Brief summary

Human immunodeficiency virus (HIV) infection has been associated with a variety of cardiovascular diseases. Even most industrialised countries exhibit a growing and aging population of HIV-infected patients in the majority treated with antiretroviral drugs, the investigators still do not know much about the impact of cardiovascular diseases in this group of patients. The present study is an ongoing trial that was conducted as a prospective and multicentre survey, being schemed to analyse the frequency and clinical course of cardiac disorders in HIV-infected patients.

Interventions

None listed

Sponsors

Federal Ministry of Education and Reserach (BMBF)
CollaboratorUNKNOWN
University Hospital, Essen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age \> 18 years * Known HIV-infection * Outpatients * Written informed consent

Exclusion criteria

● Acute cardiovascular disease or unstable hemodynamic status in the three weeks before inclusion • Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of cardiovascular diseasesPrevalence of cardiovascular diseases including coronary artery disease, congestive heart failure, peripheral arterial disease, cerebrovascular events, and valvular diseases.

Secondary

MeasureTime frameDescription
Prevalence of cardiovascular disordersPrevalence of cardiovascular disorders determined by electrocardiography, exercise testing, echocardiography, blood samples.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026